Oruka Therapeutics, Inc. (ORKA) Operating income 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual operating income history from SEC filings — each fiscal year as reported.
-$122.1MFY2025 · since FY2016: -$16.6M → -$122.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.1M | — |
| FY2023 | -$7.3M | +31.1% |
| FY2022 | -$10.6M | +45.2% |
| FY2021 | -$19.3M | -98.0% |
| FY2020 | -$9.8M | -68.0% |
| FY2019 | -$5.8M | +28.4% |
| FY2018 | -$8.1M | +56.6% |
| FY2017 | -$18.7M | -12.6% |
| FY2016 | -$16.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORKA financial trends
ORKA RevenueORKA Net incomeORKA Net marginORKA Gross profitORKA Gross marginORKA Operating marginORKA Operating cash flowORKA Free cash flowORKA Capital expendituresORKA Return on equityORKA Stock buybacksORKA Dividends paidORKA Total assetsORKA Total liabilitiesORKA Shareholders’ equityORKA overview →